Regeneron to Webcast Presentations at Two Investor Conferences
Murray A. Goldberg, Senior Vice President, Finance and Administration, and Chief Financial Officer of Regeneron, will provide an overview of the Company and its clinical programs at the NewsMakers in the Biotech Industry Conference. This presentation is scheduled to be broadcast live on Thursday, September 6, 2007 at 4:00 pm (Eastern Time).
Leonard S. Schleifer, M.D., Ph.D., President and Chief Executive Officer of Regeneron, will provide an overview of Regeneron and its clinical programs at the Bear Stearns Healthcare Conference. This presentation is scheduled to be broadcast live on Tuesday, September 11, 2007 at 8:30 am (Eastern Time).
These two sessions may be accessed through the Company's website (www.regeneron.com on the Investor Relations page, under the Events heading) at the time of the presentation. Archived versions of both presentations will be available, after the live webcasts, until October 12, 2007. Additional information about Regeneron and recent news releases are available on the Regeneron worldwide website at www.regeneron.com
Regeneron is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates for the potential treatment of cancer, eye diseases, and inflammatory diseases and has preclinical programs in other diseases and disorders.
SOURCE: Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Charles Poole, 914-345-7640
Vice President, Investor Relations
charles.poole@regeneron.com
or
Laura Lindsay, 914-345-7800
Corporate Communications
laura.lindsay@regeneron.com